Tobin Schilke Appointed Achaogen CFO
Executive Summary
Achaogen Inc. a biopharma developing antibacterial addressing multi-drug resistant gram-negative infections, has appointed Tobin Schilke chief financial officer (CFO). For 13 years Schilke was at Roche/Genentech where he was most recently CFO and company director of Roche Products Limited in the United Kingdom.